Dihydrofolate reductase I164L mutation in Plasmodium falciparum, Madagascar

Emerging Infectious Diseases

Volumn 14, Issue 7, 2008, Pages 1166-1167

  Ménard, Didier ^a   Andriantsoanirina, Valérie ^a   Jahevitra, Martial ^a   Barnadas, Céline ^a   Tichit, Magali ^b   Bouchier, Christiane ^b   Sibley, Carol Hopkins ^c  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; FANSIDAR; QUININE;

ENZYME ANALYSIS; GENE MUTATION; GENOTYPE; HUMAN; LETTER; MADAGASCAR; MALARIA FALCIPARUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PROTOZOAL GENETICS;

ADOLESCENT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG RESISTANCE; HUMANS; INFANT; MADAGASCAR; MOLECULAR SEQUENCE DATA; MUTATION; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 46349090146     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1407.071498     Document Type: Letter

References (10)

1. Institut National de la Statistique (INSTAT) (Madagascar) et ORC Macro. Enquête démographique et de santé, Madagascar 2003-2004: rapport de synthèse. Calverton (MD): INSTAT et ORC Macro; 2005.
2. Randrianarivelojosia M, Ariey F, Raharimalala LA, Parzy D, Rogier C, Jambou R. Current absence of pyrimethamine resistance of Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg. 2002;96:557-79. DOI: 10.1016/S0035-9203(02)90441-4
3. Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, et al. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006. Am J Trop Med Hyg. 2007;77:431-7.
4. Hastings MD, Bates SJ, Blackstone EA, Monks SM, Mutabingwa TK, Sibley CH. Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania. Trans R Soc Trop Med Hyg. 2002;96:674-6. DOI: 10.1016/S0035-9203(02)90349-4
5. Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev. 2005;57:117-45. DOI: 10.1124/pr.57.1.4
6. Nzila A, Ochong E, Nduati E, Gilbert K, Winstanley P, Ward S, et al. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet? Trans R Soc Trop Med Hyg. 2005;99:341-6. DOI: 10.1016/j.trstmh.2004. 07.002
7. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124. DOI: 10.1126/science.1098876
8. Noranate N, Durand R, Tall A, Marrama L, Spiegel A, Sokhna C, et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One. 2007;2:e139. DOI: 10.1371/journal.pone.0000139
9. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: The Organization; 2003.
10. McCollum AM, Poe AC, Hamel M, Huber C, Zhou Z, Shi YP, et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis. 2006;194:189-97. DOI: 10.1086/504687